Bristol Myers Squibb EBITDA 2010-2024 | BMY

Bristol Myers Squibb annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Bristol Myers Squibb EBITDA for the quarter ending March 31, 2024 was $-8.984B, a 272.8% decline year-over-year.
  • Bristol Myers Squibb EBITDA for the twelve months ending March 31, 2024 was $4.017B, a 78.77% decline year-over-year.
  • Bristol Myers Squibb 2023 annual EBITDA was $18.2B, a 1.17% increase from 2022.
  • Bristol Myers Squibb 2022 annual EBITDA was $17.989B, a 4.23% decline from 2021.
  • Bristol Myers Squibb 2021 annual EBITDA was $18.784B, a 435.31% increase from 2020.
Bristol Myers Squibb Annual EBITDA
(Millions of US $)
2023 $18,200
2022 $17,989
2021 $18,784
2020 $3,509
2019 $6,721
2018 $6,605
2017 $5,920
2016 $6,297
2015 $2,453
2014 $2,848
2013 $3,654
2012 $5,143
2011 $7,609
2010 $6,678
2009 $6,027
Bristol Myers Squibb Quarterly EBITDA
(Millions of US $)
2024-03-31 $-8,984
2023-12-31 $4,138
2023-09-30 $4,572
2023-06-30 $4,291
2023-03-31 $5,199
2022-12-31 $4,380
2022-09-30 $4,797
2022-06-30 $4,541
2022-03-31 $4,271
2021-12-31 $4,437
2021-09-30 $4,884
2021-06-30 $4,265
2021-03-31 $5,198
2020-12-31 $-7,761
2020-09-30 $4,912
2020-06-30 $4,185
2020-03-31 $2,173
2019-12-31 $1,107
2019-09-30 $1,520
2019-06-30 $1,945
2019-03-31 $2,149
2018-12-31 $1,677
2018-09-30 $2,332
2018-06-30 $674
2018-03-31 $1,922
2017-12-31 $895
2017-09-30 $1,371
2017-06-30 $1,506
2017-03-31 $2,148
2016-12-31 $1,208
2016-09-30 $1,664
2016-06-30 $1,705
2016-03-31 $1,720
2015-12-31 $-334
2015-09-30 $1,092
2015-06-30 $143
2015-03-31 $1,552
2014-12-31 $43
2014-09-30 $1,120
2014-06-30 $483
2014-03-31 $1,202
2013-12-31 $1,050
2013-09-30 $998
2013-06-30 $719
2013-03-31 $887
2012-12-31 $1,004
2012-09-30 $766
2012-06-30 $1,207
2012-03-31 $2,166
2011-12-31 $1,863
2011-09-30 $1,853
2011-06-30 $1,974
2011-03-31 $1,919
2010-12-31 $1,654
2010-09-30 $1,749
2010-06-30 $1,722
2010-03-31 $1,553
2009-12-31 $1,434
2009-09-30 $1,658
2009-06-30 $1,596
2009-03-31 $1,339
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $82.016B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $177.469B 17.76
Vertex Pharmaceuticals (VRTX) United States $126.121B 32.45
Regeneron Pharmaceuticals (REGN) United States $121.210B 29.64
CSL (CSLLY) Australia $101.203B 0.00
Gilead Sciences (GILD) United States $87.160B 17.36
GSK (GSK) United Kingdom $81.158B 9.69
Moderna (MRNA) United States $46.548B 0.00
Biogen (BIIB) United States $33.496B 15.34
Alnylam Pharmaceuticals (ALNY) United States $32.952B 0.00
Argenex SE (ARGX) Netherlands $27.720B 0.00
BioNTech SE (BNTX) Germany $20.195B 169.90
Illumina (ILMN) United States $18.493B 131.92
Genmab (GMAB) Denmark $17.888B 20.97
BioMarin Pharmaceutical (BMRN) United States $16.144B 62.98
BeiGene (BGNE) Cayman Islands $14.754B 0.00
Sarepta Therapeutics (SRPT) United States $14.378B 1267.58
Incyte (INCY) United States $14.294B 22.10
Bio-Techne Corp (TECH) United States $12.183B 46.02
Insmed (INSM) United States $11.399B 0.00
Legend Biotech (LEGN) United States $9.911B 0.00
QIAGEN (QGEN) Netherlands $9.626B 20.56
Vaxcyte (PCVX) United States $8.964B 0.00
Exact Sciences (EXAS) United States $8.555B 0.00
Roivant Sciences (ROIV) United Kingdom $8.384B 0.00
Intra-Cellular Therapies (ITCI) United States $8.249B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Ascendis Pharma (ASND) Denmark $8.041B 0.00
Blueprint Medicines (BPMC) United States $7.375B 0.00
Repligen (RGEN) United States $7.036B 91.91
Zealand Pharma (ZLDPF) Denmark $6.954B 0.00
Exelixis (EXEL) United States $6.792B 35.00
Halozyme Therapeutics (HALO) United States $6.768B 18.79
Viking Therapeutics (VKTX) United States $6.305B 0.00
Cytokinetics (CYTK) United States $5.870B 0.00
Krystal Biotech (KRYS) United States $5.801B 0.00
Nuvalent (NUVL) United States $5.077B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.917B 0.00
Apellis Pharmaceuticals (APLS) United States $4.798B 0.00
ImmunityBio (IBRX) United States $4.578B 0.00
Immunovant (IMVT) United States $4.469B 0.00
Avidity Biosciences (RNA) United States $4.285B 0.00
Alkermes (ALKS) Ireland $3.989B 15.61
Axsome Therapeutics (AXSM) United States $3.934B 0.00
Guardant Health (GH) United States $3.802B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.753B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.381B 0.00
Biohaven (BHVN) United States $3.363B 0.00
Merus (MRUS) Netherlands $3.360B 0.00
Arcellx (ACLX) United States $3.340B 0.00
Denali Therapeutics (DNLI) United States $3.260B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.239B 0.00
Twist Bioscience (TWST) United States $3.112B 0.00
Amicus Therapeutics (FOLD) United States $3.083B 0.00
SpringWorks Therapeutics (SWTX) United States $3.070B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.050B 0.00
IDEAYA Biosciences (IDYA) United States $3.027B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.964B 0.00
ADMA Biologics Inc (ADMA) United States $2.963B 116.18
ACADIA Pharmaceuticals (ACAD) United States $2.936B 0.00
MorphoSys AG (MOR) Germany $2.832B 0.00
Apogee Therapeutics (APGE) United States $2.807B 0.00
Morphic Holding (MORF) United States $2.794B 0.00
Geron (GERN) United States $2.794B 0.00
Celldex Therapeutics (CLDX) United States $2.623B 0.00
Kymera Therapeutics (KYMR) United States $2.595B 0.00
Intellia Therapeutics (NTLA) United States $2.488B 0.00
Iovance Biotherapeutics (IOVA) United States $2.443B 0.00
Certara (CERT) United States $2.442B 56.22
Myriad Genetics (MYGN) United States $2.391B 0.00
CG Oncology (CGON) United States $2.360B 0.00
Vericel (VCEL) United States $2.357B 0.00
Fortrea Holdings (FTRE) United States $2.324B 28.57
Janux Therapeutics (JANX) United States $2.293B 0.00
Beam Therapeutics (BEAM) United States $2.213B 0.00
Protagonist Therapeutics (PTGX) United States $2.119B 14.80
Edgewise Therapeutics (EWTX) United States $2.094B 0.00
Structure Therapeutics (GPCR) United States $2.046B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.043B 0.00
Bavarian Nordic (BVNRY) Denmark $2.027B 8.83
Vera Therapeutics (VERA) United States $2.003B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.996B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.976B 0.00
Arvinas (ARVN) United States $1.976B 0.00
NovoCure (NVCR) Jersey $1.935B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.917B 14.61
NeoGenomics (NEO) United States $1.889B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.859B 0.00
Novavax (NVAX) United States $1.841B 0.00
Zai Lab (ZLAB) China $1.797B 0.00
Ligand Pharmaceuticals (LGND) United States $1.789B 29.24
Galapagos (GLPG) Belgium $1.779B 0.00
Akero Therapeutics (AKRO) United States $1.776B 0.00
Neumora Therapeutics (NMRA) United States $1.763B 0.00
Keros Therapeutics (KROS) United States $1.712B 0.00
Kura Oncology (KURA) United States $1.706B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.683B 0.00
MannKind (MNKD) United States $1.552B 190.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.505B 0.00
Belite Bio (BLTE) United States $1.465B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.432B 0.00
Dynavax Technologies (DVAX) United States $1.407B 179.17
Arcus Biosciences (RCUS) United States $1.374B 0.00
ANI Pharmaceuticals (ANIP) United States $1.332B 16.54
Day One Biopharmaceuticals (DAWN) United States $1.329B 0.00
Sana Biotechnology (SANA) United States $1.318B 0.00
Vir Biotechnology (VIR) United States $1.275B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.229B 0.00
Prothena (PRTA) Ireland $1.208B 0.00
Spyre Therapeutics (SYRE) United States $1.196B 0.00
Nurix Therapeutics (NRIX) United States $1.171B 0.00
Disc Medicine (IRON) United States $1.166B 0.00
Gyre Therapeutics (GYRE) United States $1.148B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.131B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.112B 0.00
Immatics (IMTX) Germany $1.075B 0.00
Tango Therapeutics (TNGX) United States $1.064B 0.00
MiMedx (MDXG) United States $1.052B 44.56
Tyra Biosciences (TYRA) United States $1.041B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.969B 0.00
Liquidia Technologies (LQDA) United States $0.964B 0.00
Cullinan Therapeutics (CGEM) United States $0.948B 0.00
Mesoblast (MESO) Australia $0.919B 0.00
AbCellera Biologics (ABCL) Canada $0.917B 0.00
Rapport Therapeutics (RAPP) $0.908B 0.00
Viridian Therapeutics (VRDN) United States $0.886B 0.00
Cogent Biosciences (COGT) United States $0.886B 0.00
Praxis Precision Medicines (PRAX) United States $0.870B 0.00
89BIO (ETNB) United States $0.864B 0.00
Abivax SA (ABVX) France $0.858B 0.00
Nuvation Bio (NUVB) United States $0.855B 0.00
Dianthus Therapeutics (DNTH) United States $0.850B 0.00
Humacyte (HUMA) United States $0.832B 0.00
AnaptysBio (ANAB) United States $0.822B 0.00
Cytek Biosciences (CTKB) United States $0.814B 0.00
CARGO Therapeutics (CRGX) United States $0.812B 0.00
Immunome (IMNM) United States $0.809B 0.00
Pliant Therapeutics (PLRX) United States $0.769B 0.00
Tectonic Therapeutic (TECX) United States $0.761B 0.00
Travere Therapeutics (TVTX) United States $0.746B 0.00
Stoke Therapeutics (STOK) United States $0.743B 0.00
CureVac (CVAC) Germany $0.730B 0.00
Scholar Rock Holding (SRRK) United States $0.726B 0.00
Mineralys Therapeutics (MLYS) United States $0.719B 0.00
Zymeworks (ZYME) United States $0.712B 0.00
WAVE Life Sciences (WVE) Singapore $0.688B 0.00
Olema Pharmaceuticals (OLMA) United States $0.688B 0.00
Prime Medicine (PRME) United States $0.685B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.682B 0.00
Oric Pharmaceuticals (ORIC) United States $0.678B 0.00
Arbutus Biopharma (ABUS) United States $0.677B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.637B 0.00
Replimune (REPL) United States $0.636B 0.00
Applied Therapeutics (APLT) United States $0.634B 0.00
Astria Therapeutics (ATXS) United States $0.629B 0.00
REGENXBIO (RGNX) United States $0.629B 0.00
GH Research (GHRS) Ireland $0.624B 0.00
Celcuity (CELC) United States $0.624B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.624B 0.00
ArriVent BioPharma (AVBP) United States $0.616B 0.00
Terns Pharmaceuticals (TERN) United States $0.602B 0.00
Pharming Group (PHAR) Netherlands $0.590B 0.00
Adaptive Biotechnologies (ADPT) United States $0.589B 0.00
ITeos Therapeutics (ITOS) United States $0.584B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.582B 0.00
Entrada Therapeutics (TRDA) United States $0.579B 27.22
Allogene Therapeutics (ALLO) United States $0.577B 0.00
PureTech Health (PRTC) United States $0.571B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
IGM Biosciences (IGMS) United States $0.569B 0.00
ACELYRIN, INC (SLRN) United States $0.564B 0.00
Annexon (ANNX) United States $0.562B 0.00
Emergent Biosolutions (EBS) United States $0.558B 0.00
Pharming Group (PHGUF) Netherlands $0.555B 0.00
Neurogene (NGNE) United States $0.553B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.547B 0.00
PepGen (PEPG) United States $0.546B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.538B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.536B 0.00
Contineum Therapeutics (CTNM) United States $0.534B 0.00
Alector (ALEC) United States $0.534B 0.00
Third Harmonic Bio (THRD) United States $0.532B 0.00
Avid Bioservices (CDMO) United States $0.529B 0.00
Alumis (ALMS) $0.517B 0.00
Erasca (ERAS) United States $0.515B 0.00
Castle Biosciences (CSTL) United States $0.512B 0.00
Fulcrum Therapeutics (FULC) United States $0.498B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.488B 0.00
Northwest Biotherapeutics (NWBO) United States $0.486B 0.00
Ocugen (OCGN) United States $0.484B 0.00
Voyager Therapeutics (VYGR) United States $0.477B 0.00
MaxCyte (MXCT) United States $0.471B 0.00
Oculis Holding AG (OCS) Switzerland $0.461B 0.00
GRAIL (GRAL) United States $0.460B 0.00
Anavex Life Sciences (AVXL) United States $0.456B 0.00
Absci (ABSI) United States $0.456B 0.00
Editas Medicine (EDIT) United States $0.456B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.427B 0.00
Aura Biosciences (AURA) United States $0.424B 0.00
UniQure (QURE) Netherlands $0.423B 0.00
Kyverna Therapeutics (KYTX) United States $0.422B 0.00
Fate Therapeutics (FATE) United States $0.411B 0.00
Precigen (PGEN) United States $0.406B 0.00
EnGene Holdings (ENGN) United States $0.401B 0.00
Cabaletta Bio (CABA) United States $0.398B 0.00
Urogen Pharma (URGN) United States $0.397B 0.00
Anika Therapeutics (ANIK) United States $0.396B 339.12
C4 Therapeutics (CCCC) United States $0.389B 0.00
Alto Neuroscience (ANRO) United States $0.375B 0.00
Revance Therapeutics (RVNC) United States $0.374B 0.00
ALX Oncology Holdings (ALXO) United States $0.368B 0.00
AC Immune (ACIU) Switzerland $0.360B 0.00
Kamada (KMDA) Israel $0.357B 27.00
TScan Therapeutics (TCRX) United States $0.356B 0.00
Scilex Holding (SCLX) United States $0.352B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.345B 0.00
Sutro Biopharma (STRO) United States $0.340B 0.00
Agenus (AGEN) United States $0.328B 0.00
Poseida Therapeutics (PSTX) United States $0.326B 0.00
Nkarta (NKTX) United States $0.322B 0.00
Amarin (AMRN) Ireland $0.321B 0.00
Inozyme Pharma (INZY) United States $0.319B 0.00
Nautilus Biotechnology (NAUT) United States $0.317B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.316B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.316B 0.00
Cartesian Therapeutics (RNAC) United States $0.316B 0.00
XOMA (XOMA) United States $0.314B 0.00
Q32 Bio (QTTB) United States $0.313B 0.00
Solid Biosciences (SLDB) United States $0.304B 0.00
MeiraGTx Holdings (MGTX) United States $0.296B 0.00
Alimera Sciences (ALIM) United States $0.293B 0.00
Inovio Pharmaceuticals (INO) United States $0.293B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.291B 0.00
Atea Pharmaceuticals (AVIR) United States $0.289B 0.00
Jasper Therapeutics (JSPR) United States $0.288B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.282B 0.00
Tenaya Therapeutics (TNYA) United States $0.276B 0.00
Prima BioMed (IMMP) Australia $0.275B 0.00
Gossamer Bio (GOSS) United States $0.265B 0.00
CorMedix Inc (CRMD) United States $0.263B 0.00
Mersana Therapeutics (MRSN) United States $0.255B 0.00
Design Therapeutics (DSGN) United States $0.246B 0.00
23andMe Holding (ME) United States $0.237B 0.00
2seventy Bio (TSVT) United States $0.228B 0.00
Molecular Partners AG (MOLN) Switzerland $0.227B 0.00
Codexis (CDXS) United States $0.226B 0.00
Abeona Therapeutics (ABEO) United States $0.226B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.218B 0.00
Renovaro (RENB) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.212B 0.00
Oncobiologics (OTLK) United States $0.206B 0.00
Greenwich LifeSciences (GLSI) United States $0.201B 0.00
Shattuck Labs (STTK) United States $0.199B 0.00
Trevi Therapeutics (TRVI) United States $0.197B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Inhibrx Biosciences (INBX) $0.192B 0.00
Coherus BioSciences (CHRS) United States $0.190B 0.00
Biomea Fusion (BMEA) United States $0.190B 0.00
XBiotech (XBIT) United States $0.189B 0.00
Rezolute (RZLT) United States $0.189B 0.00
Rani Therapeutics Holdings (RANI) United States $0.187B 0.00
INmune Bio (INMB) United States $0.183B 0.00
Caribou Biosciences (CRBU) United States $0.182B 0.00
Generation Bio (GBIO) United States $0.182B 0.00
Candel Therapeutics (CADL) United States $0.182B 0.00
Skye Bioscience (SKYE) United States $0.181B 0.00
Ventyx Biosciences (VTYX) United States $0.180B 0.00
Innate Pharma S.A (IPHA) France $0.180B 0.00
Adherex Technologies (FENC) United States $0.175B 213.00
Adocia (ADOCY) France $0.174B 0.00
Puma Biotechnology (PBYI) United States $0.173B 10.88
Acumen Pharmaceuticals (ABOS) United States $0.169B 0.00
FibroBiologics (FBLG) United States $0.169B 0.00
G1 Therapeutics (GTHX) United States $0.167B 0.00
BioStem Technologies (BSEM) $0.166B 0.00
Adverum Biotechnologies (ADVM) United States $0.164B 0.00
Vigil Neuroscience (VIGL) United States $0.163B 0.00
ScPharmaceuticals (SCPH) United States $0.163B 0.00
Seres Therapeutics (MCRB) United States $0.162B 0.00
Zura Bio (ZURA) United States $0.162B 0.00
Syros Pharmaceuticals (SYRS) United States $0.160B 0.00
Kodiak Sciences (KOD) United States $0.158B 0.00
Elevation Oncology (ELEV) United States $0.157B 0.00
Lifecore Biomedical (LFCR) United States $0.153B 0.00
Compugen (CGEN) Israel $0.152B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.151B 0.00
PDS Biotechnology (PDSB) United States $0.150B 0.00
Compass Therapeutics (CMPX) United States $0.149B 0.00
DiaMedica Therapeutics (DMAC) United States $0.148B 0.00
Repare Therapeutics (RPTX) Canada $0.148B 0.00
Invivyd (IVVD) United States $0.142B 0.00
Inventiva S.A (IVA) France $0.141B 0.00
I-Mab (IMAB) China $0.139B 0.00
Annovis Bio (ANVS) United States $0.136B 0.00
Bluebird Bio (BLUE) United States $0.133B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.128B 0.00
Athira Pharma (ATHA) United States $0.127B 0.00
Immunic (IMUX) United States $0.124B 0.00
TELA Bio (TELA) United States $0.124B 0.00
Adagene (ADAG) China $0.122B 0.00
Nuvectis Pharma (NVCT) United States $0.121B 0.00
Seer (SEER) United States $0.120B 0.00
ATyr Pharma (ATYR) United States $0.120B 0.00
Adlai Nortye (ANL) Cayman Islands $0.120B 0.00
Rapt Therapeutics (RAPT) United States $0.120B 0.00
Semper Paratus Acquisition (TVGN) United States $0.119B 0.00
X4 Pharmaceuticals (XFOR) United States $0.118B 0.00
Opthea (OPT) Australia $0.117B 0.00
Werewolf Therapeutics (HOWL) United States $0.117B 0.00
Cellectis S.A (CLLS) France $0.116B 0.00
Akoya Biosciences (AKYA) United States $0.114B 0.00
Omega Therapeutics (OMGA) United States $0.113B 0.00
Cardiff Oncology (CRDF) United States $0.112B 0.00
CytomX Therapeutics (CTMX) United States $0.111B 7.10
Coya Therapeutics (COYA) United States $0.109B 0.00
Elutia (ELUT) United States $0.107B 0.00
VistaGen Therapeutics (VTGN) United States $0.104B 0.00
Sagimet Biosciences (SGMT) United States $0.101B 0.00
BioHarvest Sciences (CNVCF) Canada $0.100B 0.00
Adicet Bio (ACET) United States $0.099B 0.00
CervoMed (CRVO) United States $0.098B 0.00
InflaRx (IFRX) Germany $0.096B 0.00
Sangamo Therapeutics (SGMO) United States $0.094B 0.00
Clearside Biomedical (CLSD) United States $0.093B 0.00
BeyondSpring (BYSI) United States $0.091B 0.00
Boundless Bio (BOLD) United States $0.091B 0.00
Benitec Biopharma (BNTC) United States $0.089B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.089B 0.00
Eton Pharmaceuticals (ETON) United States $0.088B 85.25
HilleVax (HLVX) United States $0.087B 0.00
BioAtla (BCAB) United States $0.087B 0.00
Kronos Bio (KRON) United States $0.086B 0.00
IO Biotech (IOBT) Denmark $0.085B 0.00
Verastem (VSTM) United States $0.085B 0.00
Checkpoint Therapeutics (CKPT) United States $0.084B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.083B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.083B 0.00
Instil Bio (TIL) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
Genelux (GNLX) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Oncolytics Biotech (ONCY) Canada $0.079B 0.00
Cognition Therapeutics (CGTX) United States $0.079B 0.00
Affimed (AFMD) Germany $0.078B 0.00
DBV Technologies S.A (DBVT) France $0.077B 0.00
AN2 Therapeutics (ANTX) United States $0.077B 0.00
LENZ Therapeutics (LENZ) United States $0.077B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.077B 0.00
Earth Science Tech (ETST) United States $0.077B 0.00
Spero Therapeutics (SPRO) United States $0.076B 2.77
Allakos (ALLK) United States $0.076B 0.00
Gritstone Bio (GRTS) United States $0.071B 0.00
MediciNova (MNOV) United States $0.071B 0.00
Precision BioSciences (DTIL) United States $0.070B 0.00
Intensity Therapeutics (INTS) United States $0.070B 0.00
Connect Biopharma Holdings (CNTB) United States $0.069B 0.00
Aileron Therapeutics (ALRN) United States $0.069B 0.00
Entera Bio (ENTX) Israel $0.068B 0.00
VTv Therapeutics (VTVT) United States $0.068B 0.00
Ovid Therapeutics (OVID) United States $0.068B 0.00
China Health Industries Holdings (CHHE) China $0.068B 0.00
Galena Biopharma (SLS) United States $0.067B 0.00
Theratechnologies (THTX) Canada $0.066B 0.00
Vor Biopharma (VOR) $0.065B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.064B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.063B 0.00
HOOKIPA Pharma (HOOK) United States $0.062B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.062B 0.00
Genenta Science S.p.A (GNTA) Italy $0.060B 0.00
Leap Therapeutics (LPTX) United States $0.060B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.059B 0.00
Passage Bio (PASG) United States $0.058B 0.00
Eyenovia (EYEN) United States $0.058B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.057B 0.00
Rallybio (RLYB) United States $0.057B 0.00
Celularity (CELU) United States $0.057B 0.00
Turnstone Biologics (TSBX) United States $0.057B 0.00
Immix Biopharma (IMMX) United States $0.056B 0.00
CalciMedica (CALC) United States $0.053B 0.00
Cidara Therapeutics (CDTX) United States $0.052B 0.00
Alpha Teknova (TKNO) United States $0.052B 0.00
Aerovate Therapeutics (AVTE) United States $0.052B 0.00
Estrella Immunopharma (ESLA) United States $0.052B 0.00
Ocuphire Pharma (OCUP) United States $0.051B 0.00
Atara Biotherapeutics (ATRA) United States $0.050B 0.00
ARCA Biopharma (ABIO) United States $0.049B 0.00
Lantern Pharma (LTRN) United States $0.048B 0.00
Elicio Therapeutics (ELTX) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.046B 0.00
NextCure (NXTC) United States $0.046B 0.00
OKYO Pharma (OKYO) $0.046B 0.00
Cue Biopharma (CUE) United States $0.046B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.046B 0.00
BioXcel Therapeutics (BTAI) United States $0.045B 0.00
LakeShore Biopharma (LSB) China $0.044B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Promis Neurosciences (PMN) Canada $0.043B 0.00
Curis (CRIS) United States $0.041B 0.00
Aligos Therapeutics (ALGS) United States $0.041B 0.00
Fortress Biotech (FBIO) United States $0.039B 0.00
MiNK Therapeutics (INKT) United States $0.039B 0.00
IN8bio (INAB) United States $0.039B 0.00
Ocean Biomedical (OCEA) United States $0.038B 0.00
Carmell (CTCX) United States $0.038B 0.00
Aadi Bioscience (AADI) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Immuneering (IMRX) United States $0.037B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.037B 0.00
Cyclo Therapeutics (CYTH) United States $0.036B 0.00
Lexaria Bioscience (LEXX) Canada $0.036B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.035B 0.00
Clene (CLNN) United States $0.034B 0.00
Quince Therapeutics (QNCX) United States $0.034B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
Pluri (PLUR) Israel $0.031B 0.00
RenovoRx (RNXT) United States $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.031B 0.00
BioAffinity Technologies (BIAF) United States $0.030B 0.00
Equillium (EQ) United States $0.030B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.029B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
Longeveron (LGVN) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
SAB Biotherapeutics (SABS) United States $0.028B 0.00
Evogene (EVGN) Israel $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Beyond Air (XAIR) United States $0.026B 0.00
Orgenesis (ORGS) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
NKGen Biotech (NKGN) United States $0.025B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.025B 0.00
HCW Biologics (HCWB) United States $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
Spruce Biosciences (SPRB) United States $0.024B 0.00
Cocrystal Pharma (COCP) United States $0.023B 0.00
VBI Vaccines (VBIV) United States $0.023B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
KALA BIO (KALA) United States $0.021B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
Forte Biosciences (FBRX) United States $0.020B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
Sensei Biotherapeutics (SNSE) United States $0.018B 0.00
Evaxion Biotech (EVAX) Denmark $0.018B 0.00
Apollomics (APLM) United States $0.018B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
BRIACELL THERAP (BCTX) Canada $0.016B 0.00
Kintara Therapeutics (KTRA) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Galecto (GLTO) Denmark $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Senti Biosciences (SNTI) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Imunon (IMNN) United States $0.013B 0.00
Lumos Pharma (LUMO) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Aptose Biosciences (APTO) Canada $0.013B 0.00
Monopar Therapeutics (MNPR) United States $0.012B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
Chemomab Therapeutics (CMMB) Israel $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
AEterna Zentaris (AEZS) Canada $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Kineta (KA) United States $0.009B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
ANEW Medical (WENA) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Soligenix (SNGX) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Notable Labs (NTBL) United States $0.007B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
GeoVax Labs (GOVX) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Trevena (TRVN) United States $0.004B 0.00
Bright Minds Biosciences (DRUG) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
Cingulate (CING) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Psyence Biomedical (PBM) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00